Manufacturing of RNA-LNP-loaded Dry Powders for the treatment of Pulmonary Diseases
Time: 4:30 pm
day: Conference Day One
Details:
- Introducing a platform technology for the production of Nano-Embedded in Microparticles (NEMs)
- NEMs as a dry powder formulation suitable for pulmonary delivery
- Illustration of the NEM potential in an in vivo proof-of-concept (PoC) study and in ex vivo human lung grafts in an allergic asthma model, targeting GATA3 which plays a pivotal role in the pathophysiology of severe type-2 asthma
